KRAS and neoplasm: The KRAS StripAssayTM has high sensitivity to detect mutant KRAS occurring in 1-5% of tumour cells, and the discordance between tissue and ctDNA testing is difficult to explain given that the tissue testing for this patient was performed on an archival tissue sample containing 80% tumour cellularity.